EDIT - Editas Medicine GAAP EPS of -$0.63 misses by $0.25, revenue of $3.58M beats by $1.78M
2025-08-12 16:46:57 ET
More on Editas Medicine
- Editas Medicine: Primed For An Unlikely Comeback? It's Not Impossible
- Gene editors steady despite latest leadership shake-up at FDA
- RFK Jr. looks to fast track rare disease drug approvals (updated)
- Seeking Alpha’s Quant Rating on Editas Medicine
- Historical earnings data for Editas Medicine